Ampio Pharmaceuticals Inc. [AMEX: AMPE] stock went on an upward path that rose over 7.71% on Friday, amounting to a one-week price increase of more than 7.83%. The company report on August 3, 2022 that Ampio Pharmaceuticals Issues Letter to Stockholders.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), today released the following letter to stockholders from its Chairman, Kevin Buchi and Chief Executive Officer, Mike Martino.
Over the last 12 months, AMPE stock dropped by -94.27%. The average equity rating for AMPE stock is currently 2.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $20.84 million, with 226.09 million shares outstanding and 209.00 million shares in the current float. Compared to the average trading volume of 6.24M shares, AMPE stock reached a trading volume of 58200078 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Ampio Pharmaceuticals Inc. [AMPE]:
ROTH Capital have made an estimate for Ampio Pharmaceuticals Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 19, 2019. While these analysts kept the previous recommendation, Aegis Capital raised their target price from $15 to $16. The new note on the price target was released on March 17, 2014, representing the official price target for Ampio Pharmaceuticals Inc. stock. Previously, the target price had yet another raise to $11, while Aegis Capital analysts kept a Buy rating on AMPE stock.
The Average True Range (ATR) for Ampio Pharmaceuticals Inc. is set at 0.01 The Price to Book ratio for the last quarter was 1.10, with the Price to Cash per share for the same quarter was set at 0.11.
AMPE Stock Performance Analysis:
Ampio Pharmaceuticals Inc. [AMPE] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.83. With this latest performance, AMPE shares dropped by -13.89% in over the last four-week period, additionally sinking by -78.99% over the last 6 months – not to mention a drop of -94.27% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AMPE stock in for the last two-week period is set at 42.81, with the RSI for the last a single of trading hit 47.89, and the three-weeks RSI is set at 40.97 for Ampio Pharmaceuticals Inc. [AMPE]. The present Moving Average for the last 50 days of trading for this stock 0.1353, while it was recorded at 0.0966 for the last single week of trading, and 0.3942 for the last 200 days.
Insight into Ampio Pharmaceuticals Inc. Fundamentals:
Return on Equity for this stock declined to -76.23, with Return on Assets sitting at -55.35.
Ampio Pharmaceuticals Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.80 and a Current Ratio set at 4.80.
Ampio Pharmaceuticals Inc. [AMPE] Insider Position Details
There are presently around $3 million, or 13.70% of AMPE stock, in the hands of institutional investors. The top three institutional holders of AMPE stocks are: VANGUARD GROUP INC with ownership of 8,291,965, which is approximately -10.909% of the company’s market cap and around 7.64% of the total institutional ownership; BLACKROCK INC., holding 4,699,064 shares of the stock with an approximate value of $0.47 million in AMPE stocks shares; and MILLENNIUM MANAGEMENT LLC, currently with $0.2 million in AMPE stock with ownership of nearly 998.59% of the company’s market capitalization.
Positions in Ampio Pharmaceuticals Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 37 institutional holders increased their position in Ampio Pharmaceuticals Inc. [AMEX:AMPE] by around 5,929,931 shares. Additionally, 59 investors decreased positions by around 23,981,066 shares, while 51 investors held positions by with 537,263 shares. The mentioned changes placed institutional holdings at 30,448,260 shares, according to the latest SEC report filing. AMPE stock had 20 new institutional investments in for a total of 2,543,691 shares, while 31 institutional investors sold positions of 4,582,122 shares during the same period.